ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
2,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
3,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
3,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
4,1,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
5,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
6,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
7,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
7,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
8,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
9,1,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
10,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
10,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
11,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
12,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
13,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
14,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
15,1,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
15,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
15,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
16,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
17,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
17,2,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
18,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
18,2,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
19,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
20,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
21,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
22,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
23,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
24,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
24,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
25,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
26,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
27,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
28,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
29,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
29,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
29,3,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
30,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
31,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
32,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
33,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
33,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
34,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
35,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
36,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
36,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
37,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
38,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
39,1,Vasculitic rash,Skin vasculitides,Skin vascular abnormalities,Skin,N
40,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
40,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
41,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
41,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
41,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
42,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
42,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
43,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
44,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
45,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
46,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
46,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
47,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
48,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
49,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
50,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
51,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
52,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
52,2,Haemothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
52,3,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
53,1,Gangrene,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
53,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
53,3,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
54,1,Fat necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
54,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
55,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
55,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
55,3,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
56,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
57,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
58,1,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
58,2,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
58,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
58,4,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
58,5,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
58,6,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
58,7,Ventricular tachycardia,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
59,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
59,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
59,3,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
59,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
60,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
61,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
62,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
63,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
63,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
64,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
64,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
64,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
64,4,Oesophageal ulcer,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
65,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
65,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
65,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
65,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
66,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
67,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
68,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
69,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
70,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
71,1,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
72,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
72,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
72,3,Headache,Headaches NEC,Headaches,Nerv,N
72,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
73,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
73,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
74,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
75,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
76,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
77,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
78,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
79,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
79,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
79,3,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
79,4,Pulseless electrical activity,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
80,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
81,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
81,2,Pharyngeal oedema,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
82,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
82,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
83,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
84,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
85,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
86,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
87,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
88,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
89,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
89,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
89,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
90,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
91,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
92,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
93,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
93,2,Thrombosis mesenteric vessel,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,N
94,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
94,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
95,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
96,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
96,2,Blood thromboplastin increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
96,3,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
96,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
97,1,Stevens-Johnson syndrome,Bullous conditions,Epidermal and dermal conditions,Skin,N
98,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
98,2,Varicose vein ruptured,Varicose veins NEC,Venous varices,Vasc,N
99,1,Ecchymosis,Purpura and related conditions,Skin vascular abnormalities,Skin,N
100,1,Headache,Headaches NEC,Headaches,Nerv,N
101,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
102,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
102,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
103,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
104,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
104,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
105,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
106,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
107,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
108,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
108,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
108,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
108,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
108,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
108,6,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
109,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
110,1,Electrocardiogram change,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
110,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
111,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
112,1,Inappropriate antidiuretic hormone secretion,Posterior pituitary disorders,Hypothalamus and pituitary gland disorders,Endo,N
113,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
114,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
114,2,Cardiac death,Death and sudden death,Fatal outcomes,Genrl,Y
114,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
115,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
116,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
117,1,Skin lesion,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
117,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
118,1,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
119,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
119,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
120,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
121,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
122,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
123,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
124,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
125,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
126,1,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
127,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
128,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
128,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
128,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
129,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
130,1,Feeling of body temperature change,Feelings and sensations NEC,General system disorders NEC,Genrl,N
130,2,Headache,Headaches NEC,Headaches,Nerv,N
130,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
130,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
131,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
131,2,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
132,1,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
133,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
134,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
134,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
135,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
136,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
137,1,Cardiac output decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
137,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
138,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
138,2,Headache,Headaches NEC,Headaches,Nerv,N
138,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
139,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
140,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
141,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
142,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
142,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
142,3,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
143,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
144,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
145,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
145,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
145,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
146,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
146,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
147,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
147,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
148,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
149,1,Hyperlipidaemia,Hyperlipidaemias NEC,Lipid metabolism disorders,Metab,N
150,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
150,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
151,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
152,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
152,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
153,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
154,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
155,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
155,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
156,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
156,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
156,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
157,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
157,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
157,3,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
158,1,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
159,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
159,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
160,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
160,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
161,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
162,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
163,1,Hypospadias,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
164,1,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
165,1,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
165,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
165,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
165,4,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
165,5,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
165,6,Vasospasm,Non-site specific necrosis and vascular insufficiency NEC,"Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
166,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
167,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
168,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
169,1,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
169,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
169,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
169,4,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
170,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
171,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
171,2,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
172,1,Femur fracture,Limb fractures and dislocations,Bone and joint injuries,Inj&P,N
172,2,Head injury,Site specific injuries NEC,Injuries NEC,Inj&P,N
172,3,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
173,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
174,1,Headache,Headaches NEC,Headaches,Nerv,N
175,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
175,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
176,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
177,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
178,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
179,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
180,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
181,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
182,1,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
182,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
183,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
183,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
184,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
185,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
186,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
186,2,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
186,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
186,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
187,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
187,2,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
188,1,Headache,Headaches NEC,Headaches,Nerv,N
188,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
189,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
190,1,Cerebral dysgenesis,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
190,2,Infantile spasms,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
190,3,Pachygyria,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
191,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
192,1,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
192,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
192,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
192,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
192,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
193,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
193,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
193,3,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
194,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
194,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
194,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
195,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
196,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
196,2,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
197,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
198,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
198,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
198,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
199,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
200,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
200,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
200,3,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
201,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
201,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
201,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
202,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
203,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
204,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
205,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
205,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
206,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
206,2,Nerve compression,Mononeuropathies,Peripheral neuropathies,Nerv,N
207,1,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
207,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
208,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
209,1,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
209,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
209,3,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
210,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
210,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
211,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
211,2,Shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,Y
212,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
213,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
214,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
215,1,Adrenal haemorrhage,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,Y
215,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
215,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
215,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
216,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
217,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
218,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
219,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
220,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
221,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
222,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
223,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
224,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
225,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
226,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
227,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
228,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
229,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
229,2,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
230,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
231,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
231,2,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
232,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
232,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
233,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
233,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
233,3,Prothrombin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
234,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
235,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
236,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
237,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
238,1,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
239,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
240,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
241,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
242,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
242,2,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
242,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
243,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
244,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
244,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
245,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
245,2,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
246,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
247,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
248,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
249,1,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
250,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
251,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
252,1,Sudden death,Death and sudden death,Fatal outcomes,Genrl,Y
253,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
253,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
254,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
254,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
255,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
255,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
255,3,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
255,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
255,5,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
256,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
257,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
258,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
259,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
260,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
260,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
261,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
261,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
261,3,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
261,4,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
262,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,Y
262,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
262,3,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
263,1,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
263,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
263,3,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
264,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
265,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
265,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
266,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
266,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
266,3,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
267,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
268,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
269,1,Haemorrhagic diathesis,Bleeding tendencies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
269,2,Vasculitis,Vasculitides NEC,Vascular infections and inflammations,Vasc,N
270,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
270,2,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
271,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
272,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
272,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
272,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
272,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
273,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
274,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
275,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
276,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
276,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
277,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
278,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
279,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
279,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
279,3,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
279,4,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
279,5,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
279,6,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
279,7,Oesophagitis,Oesophagitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
279,8,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
280,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
280,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
280,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
280,4,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
280,5,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
280,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
280,7,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
280,8,Rhabdomyolysis,Myopathies,Muscle disorders,Musc,N
281,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
281,2,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
282,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
283,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
284,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
284,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
285,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,Y
286,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
287,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
288,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
289,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
289,2,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
290,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
291,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
292,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
293,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
293,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
294,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
294,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
295,1,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
295,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
296,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
297,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
298,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
299,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
299,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
299,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
300,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
300,2,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
301,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
302,1,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
302,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
303,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
304,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
304,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
305,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
306,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
307,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
307,2,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
307,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
308,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
309,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
310,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
311,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
312,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
312,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
312,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
312,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
312,5,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
313,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
313,2,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
314,1,Peritoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
315,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
316,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
316,2,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
316,3,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
317,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
317,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
318,1,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
318,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
319,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
320,1,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
320,2,Blood pH decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
320,3,Grunting,Breathing abnormalities,Respiratory disorders NEC,Resp,N
321,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
321,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
321,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
321,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
322,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
322,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
323,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
323,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
324,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
325,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
325,2,Platelet disorder,Platelet disorders NEC,Platelet disorders,Blood,N
326,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
327,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
327,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
327,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
328,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
329,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
330,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
331,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
332,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
333,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
334,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
334,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
334,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
334,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
334,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
335,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
335,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
335,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
336,1,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
337,1,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
337,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
338,1,Peritoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
339,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
340,1,Headache,Headaches NEC,Headaches,Nerv,N
340,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
340,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
341,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
342,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
343,1,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
344,1,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,Y
345,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
346,1,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
347,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
348,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
349,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
349,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
350,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
350,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
351,1,Paralysis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
351,2,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
352,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
353,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
354,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
354,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
355,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
356,1,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
357,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
358,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
359,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
359,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
359,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
360,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
361,1,Congenital ectodermal dysplasia,Skin and subcutaneous tissue disorders congenital NEC,Skin and subcutaneous tissue disorders congenital,Cong,N
362,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
363,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
363,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
364,1,Congenital hand malformation,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
365,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
366,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
367,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
367,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
368,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
369,1,Injection site atrophy,Injection site reactions,Administration site reactions,Genrl,N
370,1,Breast necrosis,Breast disorders NEC,Breast disorders,Repro,N
371,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
371,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
372,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
372,2,Petechiae,Purpura and related conditions,Skin vascular abnormalities,Skin,N
373,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
373,2,Post procedural haematoma,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
374,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
375,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
376,1,Foetal death,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
377,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
378,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
379,1,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
379,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
380,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
381,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
381,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
382,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
383,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,Y
384,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
384,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
385,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
386,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
387,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
388,1,Headache,Headaches NEC,Headaches,Nerv,N
388,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
389,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
389,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
389,3,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
389,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
389,5,Migraine,Migraine headaches,Headaches,Nerv,N
389,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
389,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
390,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
391,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
392,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
393,1,Soft tissue disorder,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
393,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
394,1,Duodenal ulcer perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
395,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
396,1,Cerebellar haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
397,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
398,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
399,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
400,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
400,2,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
401,1,Blood creatine phosphokinase increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
401,2,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
401,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
401,4,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
401,5,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
402,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
402,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
402,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
403,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
404,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
404,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
404,3,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
405,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
406,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
407,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
408,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
409,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
409,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
409,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
409,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
410,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
410,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
410,3,Paraplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
410,4,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
411,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
411,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
412,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
412,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
412,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
412,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
412,5,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
412,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
413,1,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
413,2,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
414,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
414,2,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
414,3,Hiatus hernia,Diaphragmatic hernias,Abdominal hernias and other abdominal wall conditions,Gastr,N
414,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
415,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
415,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
415,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
416,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
416,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
417,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
417,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
417,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
417,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
418,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
418,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
418,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
418,4,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
418,5,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
418,6,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
418,7,Mediastinal haematoma,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
418,8,Odynophagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
418,9,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
418,10,Oesophageal haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
418,11,Oesophageal mass,Oesophageal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
418,12,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
418,13,Oesophageal perforation,Oesophageal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
419,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
420,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
421,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
422,1,Anti-platelet antibody positive,Autoimmunity analyses,Immunology and allergy investigations,Inv,N
422,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
423,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
423,2,Helicobacter infection,Helicobacter infections,Bacterial infectious disorders,Infec,N
424,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
425,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
426,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
426,2,Subclavian vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
427,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
428,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
429,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
429,2,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
430,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
431,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
431,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
432,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
432,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
433,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
433,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
434,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
434,2,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
435,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
436,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
436,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
437,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,Y
438,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
439,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
439,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
439,3,Peripheral ischaemia,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
439,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
439,5,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
440,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
440,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
440,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
441,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
442,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
443,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
443,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
443,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
444,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
445,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
445,2,Headache,Headaches NEC,Headaches,Nerv,N
446,1,Headache,Headaches NEC,Headaches,Nerv,N
447,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
447,2,Aspiration,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
447,3,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
447,4,Hypercapnia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
447,5,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
447,6,Hypoxia,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
447,7,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
447,8,Polyneuropathy,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
447,9,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
447,10,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
448,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
448,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
449,1,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
449,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
449,3,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
449,4,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
449,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
449,6,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
449,7,Dyskinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
449,8,Ejection fraction decreased,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,9,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
449,10,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
449,11,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
449,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
449,13,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
449,14,Sinus rhythm,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
449,15,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
449,16,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
449,17,Tricuspid valve incompetence,Tricuspid valvular disorders,Cardiac valve disorders,Card,N
449,18,Ventricular dysfunction,Myocardial disorders NEC,Myocardial disorders,Card,N
450,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
450,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
450,3,Cardiac murmur,Cardiac auscultatory investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
450,4,Cardiomegaly,Myocardial disorders NEC,Myocardial disorders,Card,N
450,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,6,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
450,7,Generalised oedema,Oedema NEC,General system disorders NEC,Genrl,N
450,8,Headache,Headaches NEC,Headaches,Nerv,N
450,9,Jugular vein distension,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
450,10,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
450,11,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
450,12,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
450,13,Orthopnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
450,14,Peripartum cardiomyopathy,Pregnancy complicated by maternal disorders,Maternal complications of pregnancy,Preg,N
450,15,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
450,16,Rales,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
450,17,Sinus tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
451,1,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
452,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
453,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
454,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
455,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
456,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
457,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
458,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
459,1,Skin mass,Skin and subcutaneous conditions NEC,Skin and subcutaneous tissue disorders NEC,Skin,N
460,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
460,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
461,1,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
461,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
461,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
461,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
462,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
462,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
462,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
462,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
462,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
462,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
463,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
464,1,Cardiac disorder,Cardiac disorders NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
464,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
465,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
466,1,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
466,2,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
467,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
468,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
468,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
468,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
468,4,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
468,5,Obstructive airways disorder,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
468,6,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
468,7,Tongue haematoma,Tongue disorders,Tongue conditions,Gastr,N
468,8,Tongue haemorrhage,Tongue disorders,Tongue conditions,Gastr,N
468,9,Ventricular fibrillation,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
469,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
470,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
471,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
471,2,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
471,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
471,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
472,1,Traumatic haematoma,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
472,2,Wound sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
473,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
473,2,Troponin I increased,Skeletal and cardiac muscle analyses,Enzyme investigations NEC,Inv,N
474,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
475,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
476,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
477,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
477,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
477,3,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
477,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
477,5,Headache,Headaches NEC,Headaches,Nerv,N
477,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
478,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
478,2,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
478,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
478,4,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
479,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
480,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
480,2,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
480,3,Headache,Headaches NEC,Headaches,Nerv,N
480,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
480,5,Pituitary haemorrhage,Hypothalamic and pituitary disorders NEC,Hypothalamus and pituitary gland disorders,Endo,N
480,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
480,7,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
480,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
481,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
482,1,Hypovolaemia,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
482,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,Y
483,1,Disseminated intravascular coagulation,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
483,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
483,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
483,4,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
483,5,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
484,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
484,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
485,1,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
486,1,Headache,Headaches NEC,Headaches,Nerv,N
486,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
486,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
487,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
488,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
488,2,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
488,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
489,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
489,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
489,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
489,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
490,1,Blood pressure systolic decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
490,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
490,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
491,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
492,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
492,2,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
493,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
493,2,Macrocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
494,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
495,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
495,2,Aspartate aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
496,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
496,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
496,3,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
497,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
498,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
498,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
498,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
498,4,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
498,5,Osteopenia,Metabolic bone disorders,Bone disorders (excl congenital and fractures),Musc,N
498,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
498,7,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
499,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
499,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
499,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
500,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
500,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
501,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
501,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
502,1,Compartment syndrome,Myopathies,Muscle disorders,Musc,N
502,2,Necrosis,Necrosis NEC,Tissue disorders NEC,Genrl,N
502,3,Soft tissue haemorrhage,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
503,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
504,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
505,1,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
506,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
506,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
506,3,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
506,4,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
506,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
506,6,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
506,7,Fluid retention,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
506,8,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
506,9,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
506,10,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
506,11,Pericarditis,Noninfectious pericarditis,Pericardial disorders,Card,N
506,12,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
507,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
507,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
507,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
508,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
508,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
508,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
508,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
509,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
509,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
509,3,Nodule,Mass conditions NEC,Tissue disorders NEC,Genrl,N
509,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
510,1,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
510,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
510,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
511,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
512,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
512,2,Granulocytopenia,Neutropenias,White blood cell disorders,Blood,N
512,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
512,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
512,5,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
512,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
513,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
513,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
514,1,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
515,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
515,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
515,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
516,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
517,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
518,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
518,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
519,1,Cleft palate,Palate disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
520,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
521,1,Cleft lip,"Musculoskeletal and connective tissue disorders of face, neck and jaw congenital",Musculoskeletal and connective tissue disorders congenital,Cong,N
522,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
522,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
522,3,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
522,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
523,1,Spina bifida,Central nervous system disorders congenital NEC,Neurological disorders congenital,Cong,N
524,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
525,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
525,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
526,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
527,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
528,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
529,1,Application site vesicles,Application site reactions,Administration site reactions,Genrl,N
530,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
531,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,N
531,2,Hepatotoxicity,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
531,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
532,1,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,Y
532,2,Pulse absent,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
533,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
533,2,Haemarthrosis,Arthropathies NEC,Joint disorders,Musc,N
534,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
534,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
535,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
536,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
536,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
537,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
537,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
538,1,Procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
539,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
539,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
539,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
540,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
540,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
540,3,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
541,1,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
541,2,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
542,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
542,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
542,3,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
542,4,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
543,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
544,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
545,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
546,1,Developmental hip dysplasia,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
546,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
547,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
548,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
548,2,Hepatic enzyme abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
548,3,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
548,4,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
548,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
548,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
549,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
549,2,Genital haemorrhage,Reproductive tract disorders NEC (excl neoplasms),Reproductive tract disorders NEC,Repro,N
550,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
551,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
551,2,Mood altered,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
552,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
553,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
554,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
554,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
554,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,Y
554,4,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
554,5,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
555,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
555,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
555,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
555,4,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
555,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
555,6,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
555,7,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
555,8,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
556,1,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
556,2,Respiratory distress,Breathing abnormalities,Respiratory disorders NEC,Resp,N
557,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
557,2,Oligohydramnios,Amniotic fluid and cavity disorders of pregnancy NEC,"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
557,3,Premature labour,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
557,4,Uterine hypertonus,Maternal complications of labour NEC,Maternal complications of labour and delivery,Preg,N
558,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
559,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
559,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
559,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
559,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
560,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
561,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
561,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
562,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
562,2,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
562,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
563,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
564,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
565,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
566,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
566,2,Pulmonary haemorrhage,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
567,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
568,1,Leukopenia,Leukopenias NEC,White blood cell disorders,Blood,N
569,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
570,1,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
571,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
572,1,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
572,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
572,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
572,4,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
572,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
572,6,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
573,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
574,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
575,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
575,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
576,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
576,2,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
576,3,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
576,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
577,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
578,1,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
578,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
578,3,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
579,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
579,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
579,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
580,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
580,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
580,3,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
580,4,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
580,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
580,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
580,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
580,8,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
580,9,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
581,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
582,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
582,2,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
583,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
583,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
584,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
585,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
585,2,Mesenteric artery thrombosis,Gastrointestinal vascular occlusion and infarction,Gastrointestinal vascular conditions,Gastr,Y
586,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
586,2,Osteoporotic fracture,Fractures NEC,Fractures,Musc,N
587,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
588,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
588,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
588,3,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
588,4,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
588,5,Left atrial enlargement,Myocardial disorders NEC,Myocardial disorders,Card,N
588,6,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
588,7,Mitral valve incompetence,Mitral valvular disorders,Cardiac valve disorders,Card,N
588,8,Mitral valve stenosis,Mitral valvular disorders,Cardiac valve disorders,Card,N
588,9,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
588,10,Pulmonary hypertension,Pulmonary hypertensions,Pulmonary vascular disorders,Resp,N
588,11,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
589,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
590,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
591,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
591,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
591,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
591,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
591,5,Bone pain,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
591,6,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
591,7,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
591,8,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
591,9,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
591,10,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
591,11,Gallbladder disorder,Gallbladder disorders NEC,Gallbladder disorders,Hepat,N
591,12,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
591,13,Headache,Headaches NEC,Headaches,Nerv,N
591,14,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
591,15,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
591,16,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
591,17,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
591,18,Persistent depressive disorder,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
591,19,Proteinuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
591,20,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
591,21,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
591,22,Seborrhoea,Sebaceous gland disorders,Skin appendage conditions,Skin,N
591,23,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
591,24,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
591,25,Urine abnormality,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
591,26,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
592,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
593,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
594,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
595,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
596,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
597,1,Migraine,Migraine headaches,Headaches,Nerv,N
598,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
598,2,Intra-abdominal haematoma,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
599,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
600,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
601,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
602,1,Injection site nodule,Injection site reactions,Administration site reactions,Genrl,N
603,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
603,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
604,1,Atrial septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
604,2,Cryptorchism,Male reproductive tract disorders congenital,Reproductive tract and breast disorders congenital,Cong,N
604,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
604,4,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
604,5,Ventricular septal defect,Cardiac septal defects congenital,Cardiac and vascular disorders congenital,Cong,N
605,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
605,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
606,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
607,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
608,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
608,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
608,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
608,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
608,5,Lupus nephritis,Nephritis NEC,Nephropathies,Renal,N
608,6,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
608,7,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
609,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
609,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
610,1,Hypokalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
611,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
611,2,Injection site scab,Injection site reactions,Administration site reactions,Genrl,N
612,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
613,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
613,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
614,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
614,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
614,3,Hyperventilation,Breathing abnormalities,Respiratory disorders NEC,Resp,N
614,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
615,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
616,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
616,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
616,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
616,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
616,5,Product complaint,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
617,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
617,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
617,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
618,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
619,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,Y
620,1,Myalgia,Muscle pains,Muscle disorders,Musc,N
620,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
621,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
622,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
622,2,Agitation,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
622,3,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
622,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
622,5,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
622,6,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
623,1,Thalamus haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
624,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
625,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
625,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
625,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
625,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
625,5,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
625,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
625,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
625,8,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
625,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
626,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
626,2,DiGeorge's syndrome,Immune system abnormalities congenital,Immune system disorders congenital,Cong,N
626,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
627,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
627,2,Soft tissue necrosis,Soft tissue disorders NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
627,3,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
627,4,Wound complication,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
628,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
628,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
628,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
629,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
629,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
630,1,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
631,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
632,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
633,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
634,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
634,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
635,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
636,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
637,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
638,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
638,2,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
638,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
638,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
638,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
638,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
639,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
639,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
639,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
639,4,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
640,1,Cardiac failure congestive,Heart failures NEC,Heart failures,Card,N
640,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
640,3,Myocardial ischaemia,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
640,4,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
640,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
640,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
640,7,Tendonitis,Tendon disorders,"Tendon, ligament and cartilage disorders",Musc,N
641,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
642,1,Abdominal compartment syndrome,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
642,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
642,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
642,4,Mechanical ventilation complication,Respiratory tract and thoracic cavity procedural complications,Procedural related injuries and complications NEC,Inj&P,N
642,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
643,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
644,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
644,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
644,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
644,4,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
645,1,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
645,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
646,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
646,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
646,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
647,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
647,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
647,3,Traumatic haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,Y
648,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
648,2,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
649,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
649,2,Gingival bleeding,Gingival haemorrhages,Dental and gingival conditions,Gastr,N
649,3,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
649,4,Mucosal haemorrhage,Mucosal findings abnormal,General system disorders NEC,Genrl,N
649,5,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
649,6,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
650,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
650,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
650,3,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
651,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
652,1,Blood loss anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
652,2,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
652,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
653,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
653,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
653,3,Transient ischaemic attack,Transient cerebrovascular events,Central nervous system vascular disorders,Nerv,N
654,1,Anal abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
654,2,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
654,3,Keratoacanthoma,Skin neoplasms malignant and unspecified (excl melanoma),Skin neoplasms malignant and unspecified,Neopl,N
654,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
655,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
655,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
656,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
656,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
657,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
658,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
658,2,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
658,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
658,4,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
659,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
659,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
659,3,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
659,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
660,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
660,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
660,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
660,4,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
660,5,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
660,6,Headache,Headaches NEC,Headaches,Nerv,N
660,7,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
660,8,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
660,9,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
660,10,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
660,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
661,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
662,1,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
663,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
663,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
663,3,Intraventricular haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
663,4,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
664,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
664,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
665,1,Migraine,Migraine headaches,Headaches,Nerv,N
666,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
666,2,Injection site inflammation,Injection site reactions,Administration site reactions,Genrl,N
666,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
666,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
666,5,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
666,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
666,7,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
666,8,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
666,9,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
667,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
668,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
669,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
670,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
670,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
671,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
671,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
672,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
672,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
673,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
674,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
674,2,Radial nerve palsy,Mononeuropathies,Peripheral neuropathies,Nerv,N
675,1,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
676,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
677,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
677,2,Coma scale abnormal,Neurologic diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
677,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
677,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
677,5,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
677,6,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
677,7,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
677,8,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
677,9,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
678,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
679,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
679,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
679,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
680,1,C-reactive protein increased,Protein analyses NEC,Protein and chemistry analyses NEC,Inv,N
680,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
680,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
680,4,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
680,5,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
680,6,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
680,7,Toxic skin eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
680,8,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
681,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
681,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
681,3,Premature delivery,Labour onset and length abnormalities,Maternal complications of labour and delivery,Preg,N
682,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
682,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
683,1,Gastrooesophageal reflux disease,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
683,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
684,1,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
685,1,Ischaemic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
685,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
686,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
686,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
686,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
686,4,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
686,5,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
686,6,Panic reaction,Panic attacks and disorders,Anxiety disorders and symptoms,Psych,N
686,7,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
687,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
687,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
687,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
687,4,Lower gastrointestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
687,5,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
687,6,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
687,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
688,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
689,1,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
689,2,Dyspnoea at rest,Breathing abnormalities,Respiratory disorders NEC,Resp,N
689,3,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
689,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
689,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
690,1,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
691,1,Headache,Headaches NEC,Headaches,Nerv,N
692,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
693,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
694,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
694,2,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
695,1,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
695,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
695,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
695,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
695,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
695,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
695,7,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
695,8,Skin warm,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
695,9,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
695,10,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
695,11,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
696,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
696,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
697,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
697,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
698,1,Cerebral palsy,Cerebral disorders congenital,Neurological disorders congenital,Cong,N
698,2,Conductive deafness,Hearing losses,Hearing disorders,Ear,N
698,3,Congenital multiplex arthrogryposis,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
698,4,Congenital musculoskeletal disorder,Musculoskeletal disorders congenital NEC,Musculoskeletal and connective tissue disorders congenital,Cong,N
698,5,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
698,6,Otitis media,Ear infections,Infections - pathogen unspecified,Infec,N
698,7,Talipes,Musculoskeletal and connective tissue disorders of limbs congenital,Musculoskeletal and connective tissue disorders congenital,Cong,N
699,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
699,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
699,3,Inflammation,Inflammations,General system disorders NEC,Genrl,N
699,4,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
700,1,Acne infantile,Acnes,Skin appendage conditions,Skin,N
700,2,Drug withdrawal syndrome neonatal,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
700,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
701,1,Blood blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
701,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
701,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
702,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
703,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
703,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
704,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
705,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
705,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
705,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
706,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
707,1,Intracranial haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
708,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
708,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
708,3,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
708,4,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
709,1,Abdominal wall haemorrhage,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
709,2,Calcinosis,Trophic disorders,Tissue disorders NEC,Genrl,N
709,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
709,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
709,5,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
709,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
710,1,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
710,2,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
711,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
712,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
713,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
713,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
713,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
714,1,Hypoglycaemia,Hypoglycaemic conditions NEC,Glucose metabolism disorders (incl diabetes mellitus),Metab,N
715,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
716,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
716,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
717,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
718,1,Rheumatoid arthritis,Rheumatoid arthropathies,Joint disorders,Musc,N
719,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
719,2,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
719,3,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
720,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
720,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
721,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
721,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
721,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
721,4,Pulmonary mass,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
722,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
722,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
722,3,Wound,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
723,1,Depersonalisation/derealisation disorder,Dissociative states,Dissociative disorders,Psych,N
723,2,Disorientation,Confusion and disorientation,Deliria (incl confusion),Psych,N
723,3,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
723,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
723,5,Vertigo,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
724,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
724,2,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
725,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
725,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
726,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
727,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
727,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
727,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
727,4,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
728,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
728,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
728,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
728,4,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
728,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
728,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
728,7,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
729,1,Anaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
729,2,Apgar score low,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
729,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
729,4,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
729,5,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
730,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
730,2,Acute fatty liver of pregnancy,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
730,3,Autoimmune hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
730,4,Blood bilirubin increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
730,5,Blood lactate dehydrogenase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
730,6,Blood uric acid increased,Metabolism tests NEC,"Metabolic, nutritional and blood gas investigations",Inv,N
730,7,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
730,8,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
730,9,Hepatic artery thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
730,10,Hepatic vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
730,11,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
730,12,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
730,13,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
730,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
730,15,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
730,16,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
730,17,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
730,18,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
730,19,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
730,20,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
730,21,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
731,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
732,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
732,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
732,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
733,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
734,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
735,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
735,2,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
735,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
735,4,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
735,5,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
736,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
737,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
737,2,Muscle rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
737,3,Muscle strain,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
738,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
738,2,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
738,3,Respiratory acidosis,Conditions associated with abnormal gas exchange,Respiratory disorders NEC,Resp,N
739,1,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
740,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
740,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
740,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
741,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
741,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
741,3,Skin burning sensation,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
741,4,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
741,5,Tumour lysis syndrome,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
742,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
742,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
743,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
744,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
744,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
744,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
744,4,Subcapsular renal haematoma,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,Y
745,1,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
745,2,Gastric ulcer haemorrhage,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
745,3,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
745,4,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
746,1,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
746,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
746,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
746,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
746,5,Small intestinal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
747,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
747,2,Hypervolaemia,Total fluid volume increased,Electrolyte and fluid balance conditions,Metab,N
747,3,Renal haematoma,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,Y
748,1,Angiopathy,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
748,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
748,3,Feeling hot,Feelings and sensations NEC,General system disorders NEC,Genrl,N
748,4,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
748,5,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
748,6,Hypokinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
748,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
748,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
748,9,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
748,10,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
748,11,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
749,1,Headache,Headaches NEC,Headaches,Nerv,N
750,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
750,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
751,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
751,2,Embolic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
752,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
753,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
753,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
753,3,Localised oedema,Oedema NEC,General system disorders NEC,Genrl,N
754,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
754,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
755,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
756,1,Diabetes mellitus inadequate control,Diabetes mellitus (incl subtypes),Glucose metabolism disorders (incl diabetes mellitus),Metab,N
757,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
758,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
758,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
759,1,Rash pustular,Skin structures and soft tissue infections,Infections - pathogen unspecified,Infec,N
760,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
760,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
761,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
762,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
762,2,Hepatic enzyme increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
762,3,Lemierre syndrome,Fusobacterium infections,Bacterial infectious disorders,Infec,N
763,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
763,2,Migraine without aura,Migraine headaches,Headaches,Nerv,N
763,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
764,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
765,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
766,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
766,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
766,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
766,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
767,1,Hyponatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
767,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
768,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
768,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
768,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
768,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
768,5,Migraine,Migraine headaches,Headaches,Nerv,N
769,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
769,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
769,3,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
770,1,Application site rash,Application site reactions,Administration site reactions,Genrl,N
771,1,Conjunctival haemorrhage,Conjunctival and corneal bleeding and vascular disorders,Ocular haemorrhages and vascular disorders NEC,Eye,N
771,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
771,3,Miosis,Pupil disorders,Ocular neuromuscular disorders,Eye,N
772,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
772,2,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
773,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
774,1,Activated partial thromboplastin time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
774,2,Cerebral venous sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
774,3,Headache,Headaches NEC,Headaches,Nerv,N
774,4,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
774,5,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
774,6,Magnetic resonance imaging abnormal,Imaging procedures NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
774,7,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
775,1,Blood calcium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
775,2,Blood chloride decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
775,3,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
775,4,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
775,5,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
775,6,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
775,7,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
775,8,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
775,9,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
775,10,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
775,11,Eosinophilia,Eosinophilic disorders,White blood cell disorders,Blood,N
775,12,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
775,13,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
775,14,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
775,15,Respiratory rate increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
775,16,Septic shock,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
776,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
777,1,Drug eruption,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
777,2,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
778,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
779,1,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
779,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
779,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
780,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
781,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
782,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
782,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
783,1,Disturbance in attention,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
783,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
783,3,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
783,4,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
783,5,Labile blood pressure,Blood pressure disorders NEC,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
783,6,Tinnitus,Inner ear signs and symptoms,Inner ear and VIIIth cranial nerve disorders,Ear,N
784,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
784,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
784,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
784,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
784,5,Nervousness,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
784,6,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
785,1,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
785,2,Induration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
785,3,Urine flow decreased,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
786,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
786,2,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
786,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
786,4,Pleuritic pain,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
787,1,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
787,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
787,3,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
788,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
789,1,Road traffic accident,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
790,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
790,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
790,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
790,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
791,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
792,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
792,2,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
792,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
792,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
792,5,Pollakiuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
793,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
794,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
795,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
795,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
795,3,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
796,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
796,2,Bone disorder,Bone disorders NEC,Bone disorders (excl congenital and fractures),Musc,N
797,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
797,2,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
798,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
798,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
798,3,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
798,4,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
798,5,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
798,6,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
798,7,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
798,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
798,9,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
799,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
800,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
801,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
802,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
802,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
803,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
804,1,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
804,2,Subcutaneous haematoma,Skin injuries NEC,Injuries NEC,Inj&P,N
805,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
805,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
805,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
806,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
807,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
808,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
808,2,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
809,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
810,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
810,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
811,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
811,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
812,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
812,2,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
812,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
812,4,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
813,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
814,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
815,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
816,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
816,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
816,3,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
816,4,Erythema multiforme,Bullous conditions,Epidermal and dermal conditions,Skin,N
816,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
816,6,Protein deficiency,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
816,7,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
816,8,Scab,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
816,9,Skin erosion,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
816,10,Skin haemorrhage,Skin haemorrhages,Skin vascular abnormalities,Skin,N
816,11,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
817,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
818,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
819,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
819,2,Prescribed overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
820,1,Psoriasis,Psoriatic conditions,Epidermal and dermal conditions,Skin,N
820,2,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
821,1,Acne,Acnes,Skin appendage conditions,Skin,N
821,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
821,3,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
821,4,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
821,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
821,6,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
821,7,Eating disorder,Eating disorders NEC,Eating disorders and disturbances,Psych,N
821,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
821,9,Gait inability,Gait disturbances,General system disorders NEC,Genrl,N
821,10,Gastritis,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
821,11,Headache,Headaches NEC,Headaches,Nerv,N
821,12,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,13,Inflammatory pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
821,14,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
821,15,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
821,16,Onychalgia,Nail and nail bed conditions (excl infections and infestations),Skin appendage conditions,Skin,N
821,17,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
821,18,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
821,19,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
821,20,Plantar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
821,21,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
821,22,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
821,23,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
822,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
823,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
823,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
824,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
825,1,Drug monitoring procedure incorrectly performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
825,2,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
826,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
827,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
828,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
828,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
829,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
830,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
830,2,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
830,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
831,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
831,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
832,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
833,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
833,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
833,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
833,4,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
833,5,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
833,6,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
833,7,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
833,8,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
833,9,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
833,10,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
833,11,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
833,12,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
833,13,Device occlusion,Device malfunction events NEC,Device issues,Prod,N
833,14,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
833,15,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
833,16,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
833,17,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
833,18,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
833,19,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
833,20,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
833,21,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
833,22,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
833,23,Headache,Headaches NEC,Headaches,Nerv,N
833,24,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
833,25,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
833,26,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
833,27,Joint deposit,Joint related disorders NEC,Joint disorders,Musc,N
833,28,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
833,29,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
833,30,Muscle tightness,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
833,31,Musculoskeletal chest pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
833,32,Musculoskeletal discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
833,33,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
833,34,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
833,35,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
833,36,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
833,37,Oral mucosal roughening,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
833,38,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
833,39,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
833,40,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
833,41,Poor quality sleep,Dyssomnias,Sleep disorders and disturbances,Psych,N
833,42,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
833,43,Pulmonary thrombosis,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
833,44,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
833,45,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
833,46,Restlessness,Increased physical activity levels,Changes in physical activity,Psych,N
833,47,Sinusitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
833,48,Taste disorder,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
833,49,Tearfulness,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
833,50,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
833,51,Tongue ulceration,Tongue disorders,Tongue conditions,Gastr,N
833,52,Urinary tract obstruction,Genital and urinary tract disorders NEC,Genitourinary tract disorders NEC,Renal,N
833,53,Viral infection,Viral infections NEC,Viral infectious disorders,Infec,N
833,54,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
834,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
835,1,Gastritis haemorrhagic,Gastritis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
835,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
836,1,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
836,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
836,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
836,4,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
837,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
837,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
837,3,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
837,4,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
837,5,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
837,6,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
837,7,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
837,8,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
837,9,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
837,10,Body temperature decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
837,11,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
837,12,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
837,13,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
837,14,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
837,15,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
837,16,Hypovolaemic shock,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
837,17,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
837,18,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
837,19,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
837,20,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
837,21,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
837,22,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
837,23,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
838,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
839,1,Neutropenia,Neutropenias,White blood cell disorders,Blood,N
840,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
840,2,Gastric haemorrhage,Gastric and oesophageal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
840,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
840,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
841,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
841,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
842,1,Anal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
842,2,Diverticulitis,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
842,3,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
842,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
843,1,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
843,2,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
843,3,Growth retardation,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
843,4,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
844,1,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
844,2,Suicide attempt,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
845,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
845,2,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
846,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
846,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
846,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
847,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
847,2,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
848,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
849,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
849,2,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
850,1,Headache,Headaches NEC,Headaches,Nerv,N
851,1,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
851,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
852,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
852,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
853,1,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
854,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
854,2,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
855,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
855,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
856,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
856,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
856,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
856,4,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
856,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
856,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
856,7,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
856,8,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
856,9,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
856,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
856,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
857,1,Duodenal ulcer,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
858,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
858,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
859,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
860,1,Documented hypersensitivity to administered product,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
860,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
861,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
861,2,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
862,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
862,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
862,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
863,1,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
864,1,Non-immune heparin associated thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
865,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
866,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
866,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
867,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
867,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
867,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
868,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
868,2,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
868,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
868,4,Ovarian cyst ruptured,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
869,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
870,1,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
870,2,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
870,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
870,4,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
870,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
870,6,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
870,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
870,8,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
870,9,Splenic infarction,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
870,10,Thrombophlebitis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
870,11,Visual field defect,Visual field disorders,Vision disorders,Eye,N
871,1,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
871,2,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
872,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
873,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
873,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
873,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
873,4,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
873,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
873,6,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
873,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
874,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
875,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
875,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
875,3,Product container seal issue,Product packaging issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
876,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
877,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
877,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
877,3,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
877,4,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
878,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
878,2,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
879,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
880,1,Adrenal haemorrhage,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,Y
881,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
881,2,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
882,1,Administration site haematoma,Administration site reactions NEC,Administration site reactions,Genrl,N
882,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
882,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
882,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
883,1,Haemorrhagic stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
884,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
884,2,Headache,Headaches NEC,Headaches,Nerv,N
884,3,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
884,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
885,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
886,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
886,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
886,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
886,4,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
887,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
888,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
888,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
889,1,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
890,1,Adrenal haemorrhage,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
890,2,Adrenal insufficiency,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
890,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
891,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
892,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
892,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
893,1,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
893,2,Death,Death and sudden death,Fatal outcomes,Genrl,Y
893,3,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
894,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
895,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
895,2,Haemorrhagic transformation stroke,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
896,1,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
897,1,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
897,2,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
897,3,Subdural haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
898,1,Headache,Headaches NEC,Headaches,Nerv,N
899,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
899,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
899,3,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
899,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
899,5,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
899,6,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
900,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
900,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
901,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
901,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
901,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
902,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
902,2,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
902,3,Disability,Disability issues,Lifestyle issues,SocCi,N
902,4,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
902,5,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
902,6,Mental impairment,Mental impairment (excl dementia and memory loss),Mental impairment disorders,Nerv,N
902,7,Myalgia,Muscle pains,Muscle disorders,Musc,N
902,8,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
902,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
902,10,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
902,11,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
903,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
903,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
903,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
903,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
904,1,Full blood count abnormal,Blood counts NEC,Haematology investigations (incl blood groups),Inv,N
904,2,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
904,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
904,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
904,5,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
904,6,Systemic lupus erythematosus,Lupus erythematosus (incl subtypes),Connective tissue disorders (excl congenital),Musc,N
905,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
905,2,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
905,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
905,4,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
906,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
906,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
907,1,Drug-induced liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
908,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
909,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
909,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
909,3,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
909,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
909,5,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
909,6,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
910,1,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
911,1,Coagulation time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
911,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
912,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
912,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
912,3,Faeces discoloured,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
913,1,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,Y
914,1,Placental disorder,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
915,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
915,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
915,3,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
915,4,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
915,5,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
916,1,Gastrointestinal disorder,Gastrointestinal disorders NEC,Gastrointestinal conditions NEC,Gastr,N
916,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
916,3,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
916,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
917,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
918,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
919,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
919,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
919,3,Dry throat,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
919,4,Immunodeficiency,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
919,5,Nightmare,Parasomnias,Sleep disorders and disturbances,Psych,N
920,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
920,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
921,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
922,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
922,2,Dyschezia,Gastrointestinal dyskinetic disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
922,3,Micturition urgency,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
922,4,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
923,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
924,1,Embolism venous,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
925,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
925,2,Migraine,Migraine headaches,Headaches,Nerv,N
925,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
925,4,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
926,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
927,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
927,2,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
927,3,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
928,1,Headache,Headaches NEC,Headaches,Nerv,N
928,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
929,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
929,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
930,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
931,1,Application site pruritus,Application site reactions,Administration site reactions,Genrl,N
931,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
931,3,Injection site haematoma,Injection site reactions,Administration site reactions,Genrl,N
931,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
931,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
932,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
932,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
932,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
933,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
934,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
935,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
935,2,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
935,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
936,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
936,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
936,3,Quadriplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
936,4,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
936,5,Spinal cord haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
936,6,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
936,7,Spinal cord oedema,Spinal cord and nerve root disorders NEC,Spinal cord and nerve root disorders,Nerv,N
937,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
937,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
938,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
939,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
940,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
941,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
941,2,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
941,3,Stillbirth,Stillbirth and foetal death,Abortions and stillbirth,Preg,N
942,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
942,2,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
943,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
944,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
945,1,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
945,2,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
945,3,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
945,4,Ovarian cyst ruptured,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
946,1,Duodenal perforation,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,Y
946,2,Duodenal ulcer haemorrhage,Duodenal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
946,3,Pneumonitis,Lower respiratory tract inflammatory and immunologic conditions,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
946,4,Respiratory disorder,Respiratory tract disorders NEC,Respiratory disorders NEC,Resp,N
947,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
947,2,Drug monitoring procedure not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
947,3,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
948,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
948,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
949,1,Injection site urticaria,Injection site reactions,Administration site reactions,Genrl,N
950,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
951,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
951,2,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
952,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
953,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
953,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
953,3,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
954,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
954,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
955,1,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
955,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
955,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
955,4,Coronary artery embolism,Coronary artery disorders NEC,Coronary artery disorders,Card,N
955,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
956,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
956,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
956,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
956,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
957,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
957,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
957,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
957,4,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
958,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
958,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
959,1,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
959,2,Circulatory collapse,Circulatory collapse and shock,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
959,3,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
959,4,Electrocardiogram ST segment depression,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
959,5,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
959,6,Urine output decreased,Urinary tract function analyses NEC,Renal and urinary tract investigations and urinalyses,Inv,N
960,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
961,1,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
962,1,Eye disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
962,2,Eye infection,Eye and eyelid infections,Infections - pathogen unspecified,Infec,N
962,3,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
963,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
963,2,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
963,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
963,4,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
964,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
965,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
966,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
966,2,Mass,Mass conditions NEC,Tissue disorders NEC,Genrl,N
967,1,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
967,2,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
967,3,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
967,4,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
968,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
968,2,Low birth weight baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
968,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
969,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
969,2,Glomerular filtration rate decreased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
970,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
971,1,Therapeutic response unexpected,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
972,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
972,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
972,3,Non-cardiac chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
973,1,Blood urine present,Urinalysis NEC,Renal and urinary tract investigations and urinalyses,Inv,N
973,2,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
973,3,Depressed mood,Mood alterations with depressive symptoms,Depressed mood disorders and disturbances,Psych,N
973,4,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
973,5,Headache,Headaches NEC,Headaches,Nerv,N
973,6,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
973,7,Irritability,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
973,8,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
974,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
974,2,Transaminases increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
975,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
976,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
977,1,Extradural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
977,2,Sensory loss,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
977,3,Spinal cord haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
978,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
978,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
979,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
980,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
980,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
981,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
981,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
981,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
982,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
982,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
982,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
982,4,Crying,General signs and symptoms NEC,General system disorders NEC,Genrl,N
982,5,Depression,Depressive disorders,Depressed mood disorders and disturbances,Psych,N
982,6,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
982,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
982,8,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,Y
982,9,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
982,10,Tongue coated,Tongue signs and symptoms,Tongue conditions,Gastr,N
983,1,Blood glucose increased,Carbohydrate tolerance analyses (incl diabetes),"Metabolic, nutritional and blood gas investigations",Inv,N
983,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
983,3,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
983,4,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
983,5,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
983,6,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
984,1,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
984,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
984,3,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
985,1,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
986,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
986,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
987,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
987,2,Alopecia,Alopecias,Skin appendage conditions,Skin,N
987,3,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
987,4,Colonic abscess,Abdominal and gastrointestinal infections,Infections - pathogen unspecified,Infec,N
987,5,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
987,6,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
987,7,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
987,8,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
987,9,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
987,10,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
987,11,Movement disorder,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
987,12,Portal vein occlusion,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
987,13,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
987,14,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
987,15,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
987,16,Underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
987,17,Weight increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
988,1,Bone marrow haemorrhage,Haematological disorders,Haematological disorders NEC,Blood,N
988,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
989,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
989,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
990,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
990,2,Bleeding time prolonged,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
990,3,Blood pressure abnormal,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
990,4,Disability,Disability issues,Lifestyle issues,SocCi,N
990,5,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
990,6,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
990,7,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
990,8,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
990,9,Haematochezia,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
990,10,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
990,11,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
990,12,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
990,13,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
990,14,Overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
990,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
990,16,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
990,17,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
991,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
991,2,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
991,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
991,4,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
991,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
992,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
992,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,Y
993,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
993,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
993,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
993,4,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
993,5,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
994,1,Frequent bowel movements,Gastrointestinal spastic and hypermotility disorders,Gastrointestinal motility and defaecation conditions,Gastr,N
994,2,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
995,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
995,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
996,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
996,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
996,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
997,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
997,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
997,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
998,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
999,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
999,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
999,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
999,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
999,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1000,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1000,2,Labelled drug-drug interaction medication error,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1000,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1001,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1002,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1002,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1002,3,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1003,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1003,2,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1003,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1004,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1004,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1004,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1004,4,HELLP syndrome,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1004,5,Haemophagocytic lymphohistiocytosis,Immune and associated conditions NEC,Immune disorders NEC,Immun,N
1004,6,Hepatomegaly,Hepatobiliary signs and symptoms,Hepatic and hepatobiliary disorders,Hepat,N
1004,7,Oxygen saturation decreased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1005,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1005,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1005,3,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1005,4,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
1005,5,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1005,6,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1006,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1006,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1006,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1006,4,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1007,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1007,2,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1007,3,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1007,4,Eructation,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1007,5,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1008,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1008,2,Vascular device infection,Vascular infections,Infections - pathogen unspecified,Infec,N
1009,1,Contraindicated product administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1009,2,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1010,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1011,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1011,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1012,1,Wheezing,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
1013,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1014,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1014,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1015,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1015,2,Exposure via breast milk,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1016,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1016,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1016,3,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1017,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1018,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1019,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1020,1,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1020,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1021,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1021,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1022,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1022,2,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1023,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1024,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1024,2,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1025,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1025,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1026,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1027,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1028,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1029,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1030,1,Aspiration pleural cavity,Respiratory tract and thoracic histopathology procedures,Respiratory and pulmonary investigations (excl blood gases),Inv,N
1030,2,Congenital anomaly,Congenital disorders NEC,Congenital and hereditary disorders NEC,Cong,N
1030,3,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1030,4,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1030,5,Pulmonary hypoplasia,Pulmonary and bronchial disorders congenital,Respiratory disorders congenital,Cong,Y
1030,6,Pulmonary oedema neonatal,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1031,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1031,2,Artificial rupture of membranes,Obstetric therapeutic procedures,Obstetric and gynaecological therapeutic procedures,Surg,N
1031,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1032,1,Adverse event,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1032,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1033,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1034,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1035,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1035,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1035,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1036,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1036,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1036,3,Rash maculo-papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1036,4,Skin texture abnormal,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1037,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1038,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1039,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1040,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1040,2,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1040,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1041,1,Abdominal mass,Abdominal findings abnormal,Gastrointestinal signs and symptoms,Gastr,N
1041,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1042,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1043,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1043,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1043,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1043,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1043,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1043,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1043,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1043,8,Hypocoagulable state,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1043,9,Splenic haemorrhage,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1043,10,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1043,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1044,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1044,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
1044,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1044,4,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1045,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1045,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1045,3,Anuria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1045,4,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,N
1045,5,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1045,6,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1045,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1045,8,Hypocoagulable state,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
1045,9,Splenic haemorrhage,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1045,10,Supraventricular tachycardia,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1045,11,Toxicity to various agents,Poisoning and toxicity,"Exposures, chemical injuries and poisoning",Inj&P,N
1046,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1047,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1047,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1048,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1048,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1048,3,Dysuria,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1048,4,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1048,5,Haemorrhagic ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
1048,6,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1048,7,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1049,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1050,1,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1050,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1050,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1050,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1050,5,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1051,1,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1051,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1052,1,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1053,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1053,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1054,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1054,2,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1055,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1055,2,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1055,3,Haemorrhagic ovarian cyst,Ovarian and fallopian tube cysts and neoplasms,Ovarian and fallopian tube disorders,Repro,N
1055,4,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1056,1,Balanitis candida,Candida infections,Fungal infectious disorders,Infec,N
1057,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1058,1,Administration site rash,Administration site reactions NEC,Administration site reactions,Genrl,N
1058,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1059,1,Contraindicated product prescribed,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1059,2,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1060,1,Dose calculation error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1060,2,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1061,1,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1061,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1062,1,Calciphylaxis,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,Y
1062,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1063,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1064,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
1064,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1064,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1065,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1065,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1066,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1067,1,Illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1068,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1068,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1068,3,Maternal death affecting foetus,Foetal conditions due to maternal conditions,Foetal complications,Preg,N
1069,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1069,2,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1069,3,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1070,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1070,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1071,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1072,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1072,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1073,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1074,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1075,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1075,2,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1075,3,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1076,1,Gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1077,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1078,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,Y
1079,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1080,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1080,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1080,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1080,4,Abdominal tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1080,5,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1080,6,Abdominal wall oedema,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1080,7,Acidosis,Mixed acid-base disorders,Acid-base disorders,Metab,N
1080,8,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1080,9,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1080,10,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1080,11,Intra-abdominal pressure increased,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
1080,12,Oliguria,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1080,13,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1080,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1081,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1082,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1083,1,Abdominal pain lower,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1083,2,Abdominal rebound tenderness,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1083,3,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1083,4,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1083,5,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1083,6,Clostridium difficile colitis,Clostridia infections,Bacterial infectious disorders,Infec,N
1083,7,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1083,8,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1083,9,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1083,10,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1084,1,Traumatic intracranial haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1085,1,Adrenocortical insufficiency acute,Adrenal cortical hypofunctions,Adrenal gland disorders,Endo,N
1085,2,Blood disorder,Haematological disorders,Haematological disorders NEC,Blood,N
1085,3,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1085,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1085,5,Hydronephrosis,Renal obstructive disorders,Renal disorders (excl nephropathies),Renal,N
1085,6,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1085,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1085,8,Venous thrombosis limb,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1086,1,Traumatic intracranial haemorrhage,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1087,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1088,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1089,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1090,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1091,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1091,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1092,1,Prescribed underdose,Underdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1092,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1092,3,Therapeutic drug monitoring analysis not performed,Product monitoring errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1093,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1094,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1095,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1095,2,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1095,3,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1096,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1097,1,Abortion spontaneous,Abortions spontaneous,Abortions and stillbirth,Preg,N
1097,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1098,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1099,1,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1099,2,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1099,3,Purpura,Purpura and related conditions,Skin vascular abnormalities,Skin,N
1100,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1100,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1101,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1101,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1101,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1102,1,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1103,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1103,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
1103,3,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
1104,1,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1104,2,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1104,3,Drug interaction,Interactions,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1104,4,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1104,5,Headache,Headaches NEC,Headaches,Nerv,N
1104,6,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
1104,7,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1104,8,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1104,9,Nervous system disorder,Nervous system disorders NEC,Neurological disorders NEC,Nerv,N
1104,10,Speech disorder,Speech and language abnormalities,Neurological disorders NEC,Nerv,N
1104,11,Vertebrobasilar artery dissection,Central nervous system aneurysms and dissections,Central nervous system vascular disorders,Nerv,N
1105,1,Diabetic ketoacidosis,Diabetic complications NEC,Diabetic complications,Metab,N
1106,1,Electrocardiogram QT prolonged,ECG investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1106,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1106,3,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1107,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1107,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1107,3,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1107,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1108,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1108,2,Atrial fibrillation,Supraventricular arrhythmias,Cardiac arrhythmias,Card,N
1108,3,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
1108,4,Cardiac tamponade,Pericardial disorders NEC,Pericardial disorders,Card,N
1108,5,Cardiogenic shock,Heart failures NEC,Heart failures,Card,N
1108,6,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1108,7,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1109,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1110,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1110,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1110,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1111,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1112,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1112,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1113,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1113,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1113,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1114,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1114,2,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1115,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1115,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1116,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1117,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1117,2,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1118,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1118,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1118,3,Embolism,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
1118,4,Joint swelling,Joint related signs and symptoms,Joint disorders,Musc,N
1118,5,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1118,6,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1119,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1120,1,Eczema,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1120,2,Eczema impetiginous,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1120,3,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1120,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1120,5,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1120,6,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1120,7,Type IV hypersensitivity reaction,Allergic conditions NEC,Allergic conditions,Immun,N
1120,8,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1121,1,Application site urticaria,Application site reactions,Administration site reactions,Genrl,N
1122,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
1123,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1124,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1125,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1126,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1126,2,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1127,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1127,2,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1128,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1128,2,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1128,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1128,4,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1128,5,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1129,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1130,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1130,2,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1130,3,Cardiac arrest,Ventricular arrhythmias and cardiac arrest,Cardiac arrhythmias,Card,Y
1130,4,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1130,5,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1130,6,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1130,7,Pneumomediastinum,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
1130,8,Renal disorder,Renal disorders NEC,Renal disorders (excl nephropathies),Renal,N
1130,9,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1130,10,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
1131,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1132,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1133,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1134,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1135,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1135,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1135,3,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
1135,4,Headache,Headaches NEC,Headaches,Nerv,N
1135,5,Superior sagittal sinus thrombosis,Cerebrovascular venous and sinus thrombosis,Central nervous system vascular disorders,Nerv,N
1136,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1136,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1136,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1137,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1137,2,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1137,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1138,1,Device issue,Device issues NEC,Device issues,Prod,N
1138,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1138,3,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1138,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1139,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1139,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1140,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1140,2,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1141,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1141,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1142,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1143,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1144,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1144,2,Autoimmune disorder,Autoimmune disorders NEC,Autoimmune disorders,Immun,N
1144,3,Brain injury,Structural brain disorders NEC,Structural brain disorders,Nerv,N
1144,4,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1144,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1144,6,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1145,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1145,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1146,1,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
1146,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1146,3,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1146,4,Heart rate decreased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1146,5,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1147,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1147,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1147,3,Dysstasia,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1147,4,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1147,5,Headache,Headaches NEC,Headaches,Nerv,N
1147,6,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1147,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
1147,8,Throat tightness,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1148,1,Bile acids increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1148,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
1148,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1148,4,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1149,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1150,1,Incorrect route of product administration,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1150,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1151,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1151,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1151,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1151,4,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1151,5,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
1152,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1152,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1153,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
1153,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1153,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1153,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1153,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1154,1,Portal vein thrombosis,Hepatic vascular disorders,Hepatic and hepatobiliary disorders,Hepat,N
1155,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1155,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1155,3,Tenderness,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1156,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1156,2,Discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1156,3,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1156,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1157,1,Device issue,Device issues NEC,Device issues,Prod,N
1157,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1157,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1158,1,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1159,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1159,2,Headache,Headaches NEC,Headaches,Nerv,N
1159,3,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1159,4,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1160,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1161,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1161,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1161,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1161,4,Headache,Headaches NEC,Headaches,Nerv,N
1161,5,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1162,1,Platelet count decreased,Platelet analyses,Haematology investigations (incl blood groups),Inv,N
1163,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1163,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1163,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1164,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1164,2,Vaccination site induration,Vaccination site reactions,Administration site reactions,Genrl,N
1164,3,Vaccination site mass,Vaccination site reactions,Administration site reactions,Genrl,N
1165,1,Anal incontinence,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1166,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,Y
1166,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1167,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1168,1,Coordination abnormal,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
1168,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1168,3,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1169,1,Dyspnoea exertional,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1169,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1170,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1171,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1172,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1172,2,Tendon rupture,"Muscle, tendon and ligament injuries",Injuries NEC,Inj&P,N
1172,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1173,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1173,2,Device operational issue,Device operational issues NEC,Device issues,Prod,N
1173,3,Device safety feature issue,Device issues NEC,Device issues,Prod,N
1174,1,Spontaneous heparin-induced thrombocytopenia syndrome,Thrombocytopenias,Platelet disorders,Blood,N
1175,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1176,1,Adverse drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1177,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1177,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1177,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1178,1,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1179,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1179,2,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1179,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1180,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1181,1,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
1182,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1182,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1182,3,Arterial haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1182,4,Atelectasis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1182,5,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1182,6,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1182,7,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
1182,8,Ureteric dilatation,Ureteric disorders NEC,Ureteric disorders,Renal,N
1182,9,Ureteric obstruction,Ureteric disorders NEC,Ureteric disorders,Renal,N
1183,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1183,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1184,1,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1184,2,Puncture site haemorrhage,Administration site reactions NEC,Administration site reactions,Genrl,N
1185,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1185,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1186,1,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1187,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1188,1,Device safety feature issue,Device issues NEC,Device issues,Prod,N
1188,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1188,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1189,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
1190,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1191,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1191,2,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1191,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1191,4,Pelvic haematoma,Pelvis and broad ligament disorders NEC,"Uterine, pelvic and broad ligament disorders",Repro,N
1191,5,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1192,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1192,2,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1193,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1194,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1195,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1195,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1195,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1196,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1196,2,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1196,3,Skin irritation,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1197,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1198,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
1199,1,Administration site bruise,Administration site reactions NEC,Administration site reactions,Genrl,N
1200,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1201,1,Rash papular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1201,2,Vitreous floaters,"Choroid and vitreous structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
1202,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1203,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1203,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1204,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1204,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1204,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1204,4,Skin wrinkling,Skin dystrophies,Cornification and dystrophic skin disorders,Skin,N
1205,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1206,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1206,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1207,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1208,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1208,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1209,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1209,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1210,1,Urinary incontinence,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
1211,1,Haemorrhage subcutaneous,Skin haemorrhages,Skin vascular abnormalities,Skin,N
1212,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,Y
1212,2,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1213,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1213,2,Product prescribing error,Product prescribing errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1213,3,Unresponsive to stimuli,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1214,1,Rash erythematous,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1215,1,Dry eye,Lacrimation disorders,Eye disorders NEC,Eye,N
1215,2,Dry skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1215,3,Eye discharge,"Ocular infections, inflammations and associated manifestations","Ocular infections, irritations and inflammations",Eye,N
1215,4,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
1215,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1216,1,General physical health deterioration,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1216,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1216,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,Y
1217,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1218,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1219,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1219,2,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1220,1,Hiccups,Lower respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1221,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1221,2,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1221,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1221,4,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1222,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1222,2,Normal newborn,Normal newborn status,"Pregnancy, labour, delivery and postpartum conditions",Preg,N
1223,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1223,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1223,3,Post procedural haemorrhage,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
1224,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1224,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1225,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1225,2,No adverse event,Adverse effect absent,General system disorders NEC,Genrl,N
1226,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1227,1,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1227,2,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1228,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1228,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1229,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1230,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1230,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1231,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1232,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
1232,2,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1233,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1233,2,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1233,3,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1234,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1234,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1234,3,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1234,4,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1235,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1236,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1237,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1238,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1239,1,Cerebrovascular accident,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1240,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1240,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1240,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1240,4,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1240,5,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1240,6,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1241,1,Anxiety,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
1242,1,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1242,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1242,3,Pain of skin,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1242,4,Skin swelling,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1243,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1244,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1245,1,Menstrual disorder,Menstruation and uterine bleeding NEC,Menstrual cycle and uterine bleeding disorders,Repro,N
1246,1,Device malfunction,Device malfunction events NEC,Device issues,Prod,N
1246,2,Injury associated with device,Complications associated with device NEC,Complications associated with device,Genrl,N
1247,1,Thrombocytosis,Thrombocytoses,Platelet disorders,Blood,N
1248,1,Cerebral haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1249,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1249,2,Surgery,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1250,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1251,1,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1251,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1252,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1253,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1253,2,Dysphonia,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
1254,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1255,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1255,2,Injection site infection,Infections NEC,Infections - pathogen unspecified,Infec,N
1255,3,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1256,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
1256,2,Scar,Skin injuries NEC,Injuries NEC,Inj&P,N
1257,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1258,1,Lipohypertrophy,Lipodystrophies,Skin and subcutaneous tissue disorders NEC,Skin,N
1259,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1259,2,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1259,3,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1259,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1260,1,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1261,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1262,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1263,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1263,2,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1263,3,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1264,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1264,2,Obsessive-compulsive disorder,Obsessive-compulsive disorders and symptoms,Anxiety disorders and symptoms,Psych,N
1264,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1265,1,Loss of bladder sensation,Myoneurogenic bladder disorders,Bladder and bladder neck disorders (excl calculi),Renal,N
1266,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1267,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1267,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1267,3,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1267,4,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1268,1,Injection site scar,Injection site reactions,Administration site reactions,Genrl,N
1269,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1270,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,Y
1270,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1271,1,Maternal exposure before pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1271,2,Maternal exposure during delivery,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1272,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1272,2,Injection site discharge,Injection site reactions,Administration site reactions,Genrl,N
1273,1,Liver injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1274,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1274,2,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1274,3,Urinary tract infection,Urinary tract infections,Infections - pathogen unspecified,Infec,N
1275,1,Device breakage,Device physical property and chemical issues,Device issues,Prod,N
1275,2,Device defective,Device physical property and chemical issues,Device issues,Prod,N
1275,3,Device delivery system issue,Device issues NEC,Device issues,Prod,N
1275,4,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1275,5,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1275,6,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1275,7,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1276,1,Hypomenorrhoea,Menstruation with decreased bleeding,Menstrual cycle and uterine bleeding disorders,Repro,N
1277,1,Blood test abnormal,Investigations NEC,"Investigations, imaging and histopathology procedures NEC",Inv,N
1277,2,Intentional product misuse,Intentional product misuses,Off label uses and intentional product misuses/use issues,Inj&P,N
1278,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1278,2,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1279,1,Headache,Headaches NEC,Headaches,Nerv,N
1280,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1281,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1281,2,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
1281,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1282,1,Duodenitis,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
1282,2,Gastric ulcer,Gastric ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
1282,3,Subarachnoid haemorrhage,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1283,1,Non-immune heparin associated thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1284,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1285,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1286,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1287,1,Adverse reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1287,2,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1287,3,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1288,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1288,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1289,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1289,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1289,3,Injection site pruritus,Injection site reactions,Administration site reactions,Genrl,N
1289,4,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1289,5,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1290,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1290,2,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
1290,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1291,1,Pharyngeal swelling,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
1292,1,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1292,2,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1292,3,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1292,4,Subcapsular splenic haematoma,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1293,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1294,1,Self-medication,Therapeutic procedures NEC,Therapeutic procedures and supportive care NEC,Surg,N
1295,1,Cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
1296,1,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1296,2,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1296,3,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1296,4,Subcapsular splenic haematoma,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1297,1,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1298,1,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
1298,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1298,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1299,1,Haematoma muscle,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1299,2,Headache,Headaches NEC,Headaches,Nerv,N
1299,3,Intentional overdose,Overdoses NEC,Overdoses and underdoses NEC,Inj&P,N
1299,4,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1299,5,Muscle haemorrhage,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1299,6,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1299,7,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1299,8,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1300,1,Haemorrhage intracranial,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1301,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1301,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1302,1,Rash macular,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1303,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1304,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1304,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1304,3,Lung neoplasm malignant,Respiratory tract and pleural neoplasms malignant cell type unspecified NEC,Respiratory and mediastinal neoplasms malignant and unspecified,Neopl,N
1304,4,Ovarian cancer,Ovarian neoplasms malignant (excl germ cell),Reproductive neoplasms female malignant and unspecified,Neopl,N
1305,1,Headache,Headaches NEC,Headaches,Nerv,N
1306,1,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1307,1,Intra-abdominal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1308,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
1308,2,Arthralgia,Joint related signs and symptoms,Joint disorders,Musc,N
1308,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1308,4,Ear pain,Ear disorders NEC,Aural disorders NEC,Ear,N
1308,5,Headache,Headaches NEC,Headaches,Nerv,N
1308,6,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1308,7,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
1308,8,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1308,9,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1308,10,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1309,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1309,2,Cerebral thrombosis,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1309,3,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1309,4,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
1309,5,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1309,6,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1309,7,Headache,Headaches NEC,Headaches,Nerv,N
1309,8,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1309,9,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
1309,10,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1310,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1311,1,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1311,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1312,1,Furuncle,Staphylococcal infections,Bacterial infectious disorders,Infec,N
1313,1,Abortion induced,Induced abortions,Obstetric and gynaecological therapeutic procedures,Surg,N
1313,2,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1313,3,Cardiac monitoring,Cardiac function diagnostic procedures,Cardiac and vascular investigations (excl enzyme tests),Inv,N
1313,4,Cerebral haematoma,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,N
1313,5,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1314,1,Cardiac failure,Heart failures NEC,Heart failures,Card,N
1314,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1314,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1314,4,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
1314,5,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1315,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1316,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1317,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1318,1,Anaemia,Anaemias NEC,Anaemias nonhaemolytic and marrow depression,Blood,N
1318,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1318,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1318,4,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1318,5,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1319,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1320,1,Skin ulcer,Skin and subcutaneous tissue ulcerations,Skin and subcutaneous tissue disorders NEC,Skin,N
1321,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1322,1,Haemodynamic instability,Non-site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1322,2,Haemoperitoneum,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1322,3,Splenic rupture,Abdominal and gastrointestinal injuries NEC,Injuries NEC,Inj&P,N
1322,4,Subcapsular splenic haematoma,Spleen disorders,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
1323,1,Dyspepsia,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
1324,1,Anorectal malformation,Anorectal disorders congenital,Gastrointestinal tract disorders congenital,Cong,N
1324,2,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
1324,3,Blood bicarbonate increased,Blood gas and acid base analyses,"Metabolic, nutritional and blood gas investigations",Inv,N
1324,4,Blood sodium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
1324,5,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1324,6,Colitis,Colitis (excl infective),Gastrointestinal inflammatory conditions,Gastr,N
1324,7,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1324,8,Haematocrit decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,9,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,10,Lymphocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,11,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
1324,12,Mean cell haemoglobin increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,13,Mean cell volume increased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,14,Monocyte count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,15,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1324,16,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
1324,17,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,18,Neutrophil count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,19,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1324,20,Red blood cell count decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,21,Ulcer,Ulcers NEC,Tissue disorders NEC,Genrl,N
1324,22,White blood cell count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1324,23,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1325,1,Aortic intramural haematoma,Aortic aneurysms and dissections,Aneurysms and artery dissections,Vasc,N
1326,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1327,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1327,2,Injection site discolouration,Injection site reactions,Administration site reactions,Genrl,N
1327,3,Injection site necrosis,Injection site reactions,Administration site reactions,Genrl,N
1327,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1327,5,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
1328,1,Retinal migraine,Migraine headaches,Headaches,Nerv,N
1329,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1329,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1329,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
1329,4,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1330,1,Rectal haemorrhage,Intestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1331,1,Dermatitis allergic,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1332,1,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
1333,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1333,2,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1334,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1335,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1335,2,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1335,3,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
1336,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1337,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1338,1,Device safety feature issue,Device issues NEC,Device issues,Prod,N
1338,2,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1339,1,Wound haemorrhage,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
1340,1,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1340,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1341,1,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1341,2,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1341,3,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1342,1,Incorrect dose administered,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1342,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1342,3,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1343,1,Cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1343,2,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1343,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1343,4,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1344,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1345,1,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1345,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1345,3,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1345,4,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1345,5,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
1345,6,Injection site swelling,Injection site reactions,Administration site reactions,Genrl,N
1345,7,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
1345,8,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
1345,9,Palpitations,Cardiac signs and symptoms NEC,"Cardiac disorders, signs and symptoms NEC",Card,N
1345,10,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1345,11,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
1346,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1347,1,Hot flush,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
1347,2,Photopsia,Visual disorders NEC,Vision disorders,Eye,N
1348,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1349,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1350,1,International normalised ratio increased,Coagulation and bleeding analyses,Haematology investigations (incl blood groups),Inv,N
1351,1,Haemoptysis,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1351,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
1352,1,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1352,2,Pre-eclampsia,Hypertension associated disorders of pregnancy,Maternal complications of pregnancy,Preg,N
1353,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1354,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1354,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1355,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1355,2,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1355,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1355,4,Product administered at inappropriate site,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
1356,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1356,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1357,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1358,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
1359,1,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1359,2,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1360,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1361,1,Acute hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1362,1,Hepatic failure,Hepatic failure and associated disorders,Hepatic and hepatobiliary disorders,Hepat,Y
1363,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1363,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1363,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1363,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1363,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1363,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1363,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1363,8,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1363,9,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1363,10,Internal haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1363,11,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1363,12,Peripheral coldness,"Peripheral vasoconstriction, necrosis and vascular insufficiency","Arteriosclerosis, stenosis, vascular insufficiency and necrosis",Vasc,N
1363,13,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1363,14,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1363,15,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1363,16,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1364,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
1365,1,Acute generalised exanthematous pustulosis,Pustular conditions,Epidermal and dermal conditions,Skin,N
1366,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1366,2,Injection site haemorrhage,Injection site reactions,Administration site reactions,Genrl,N
1366,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1367,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
1367,2,Abdominal wall haematoma,Abdominal wall conditions NEC,Abdominal hernias and other abdominal wall conditions,Gastr,N
1367,3,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
1367,4,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1367,5,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
1367,6,Haemoglobin decreased,Red blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1367,7,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
1367,8,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1367,9,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1367,10,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
1367,11,Product use issue,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
1367,12,Retroperitoneal haematoma,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1367,13,Retroperitoneal haemorrhage,Peritoneal and retroperitoneal haemorrhages,Peritoneal and retroperitoneal conditions,Gastr,N
1367,14,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
1368,1,Skin reaction,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1369,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1369,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1369,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1370,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
1371,1,Alopecia,Alopecias,Skin appendage conditions,Skin,N
1372,1,Headache,Headaches NEC,Headaches,Nerv,N
1372,2,Limb discomfort,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1372,3,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1373,1,Insomnia,Disturbances in initiating and maintaining sleep,Sleep disorders and disturbances,Psych,N
1374,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
1375,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1376,1,Haematuria,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
1376,2,Urinary bladder haemorrhage,Bladder disorders NEC,Bladder and bladder neck disorders (excl calculi),Renal,N
1377,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1378,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1378,2,Injection site irritation,Injection site reactions,Administration site reactions,Genrl,N
1378,3,Injection site rash,Injection site reactions,Administration site reactions,Genrl,N
1378,4,Skin abrasion,Skin injuries NEC,Injuries NEC,Inj&P,N
1379,1,Contusion,Skin injuries NEC,Injuries NEC,Inj&P,N
1379,2,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1379,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1379,4,Skin fissures,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1380,1,Cervix haemorrhage uterine,Cervix disorders NEC,Cervix disorders (excl infections and inflammations),Repro,N
1381,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
1382,1,Adrenal haemorrhage,Adrenal gland disorders NEC,Adrenal gland disorders,Endo,N
1382,2,Akinesia,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
1382,3,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
1382,4,Coronary artery occlusion,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1382,5,Coronary artery thrombosis,Coronary artery disorders NEC,Coronary artery disorders,Card,N
1382,6,Deep vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1382,7,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
1382,8,Heparin-induced thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1382,9,Left ventricular hypertrophy,Myocardial disorders NEC,Myocardial disorders,Card,N
1382,10,Myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,Y
1382,11,Pelvic venous thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1382,12,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
1382,13,Pulmonary oedema,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
1382,14,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
1382,15,Superficial vein thrombosis,Peripheral embolism and thrombosis,Embolism and thrombosis,Vasc,N
1383,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1384,1,Fear of injection,Fear symptoms and phobic disorders (incl social phobia),Anxiety disorders and symptoms,Psych,N
1384,2,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1384,3,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1384,4,Needle issue,Device physical property and chemical issues,Device issues,Prod,N
1385,1,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
1386,1,Upper gastrointestinal haemorrhage,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1387,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1388,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1388,2,Headache,Headaches NEC,Headaches,Nerv,N
1388,3,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1388,4,Vaginal haemorrhage,Vulvovaginal disorders NEC,Vulvovaginal disorders (excl infections and inflammations),Repro,N
1389,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
1389,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1390,1,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1390,2,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1390,3,Maternal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1391,1,Stoma site haemorrhage,Stoma complications,Procedural related injuries and complications NEC,Inj&P,N
1392,1,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
1393,1,Epistaxis,Nasal disorders NEC,Upper respiratory tract disorders (excl infections),Resp,N
1394,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1395,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
1396,1,Maternal exposure during breast feeding,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
1396,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1397,1,Hernia,Hernias NEC,General system disorders NEC,Genrl,N
1398,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
1399,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1400,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1401,1,Dizziness postural,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
1402,1,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
1403,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1403,2,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
1404,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1404,2,Syringe issue,Device physical property and chemical issues,Device issues,Prod,N
1405,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1406,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1406,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
1407,1,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1407,2,Injection site reaction,Injection site reactions,Administration site reactions,Genrl,N
1408,1,Angioedema,Angioedemas,Angioedema and urticaria,Skin,N
1408,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1409,1,Dermatitis,Dermatitis and eczema,Epidermal and dermal conditions,Skin,N
1409,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
1410,1,Accidental exposure to product,Accidental exposures to product,Medication errors and other product use errors and issues,Inj&P,N
1410,2,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1411,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
1412,1,Melaena,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
1413,1,Idiosyncratic drug reaction,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
1414,1,Subdural haematoma,Cerebral injuries NEC,Injuries NEC,Inj&P,N
1415,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
1416,1,Injection site bruising,Injection site reactions,Administration site reactions,Genrl,N
1416,2,Injection site discomfort,Injection site reactions,Administration site reactions,Genrl,N
1416,3,Injection site mass,Injection site reactions,Administration site reactions,Genrl,N
1416,4,Injection site pain,Injection site reactions,Administration site reactions,Genrl,N
1416,5,Product quality issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1416,6,Product substitution issue,Product quality issues NEC,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
1416,7,Stress,Anxiety symptoms,Anxiety disorders and symptoms,Psych,N
